Literature DB >> 18547291

A prospective audit of regional anaesthesia failure in 5080 Caesarean sections.

S M Kinsella1.   

Abstract

Anaesthesia for Caesarean section was audited over a 5 year period: 5080 cases were performed using spinal 63%, epidural top-up 26%, combined spinal-epidural 5% and primary general anaesthesia 5%. The rate of general anaesthesia conversion of regional anaesthesia was 0.8% for elective and 4.9% for emergency Caesarean section compared to Royal College of Anaesthetists targets of 1% and 3%. The rate of conversion of regional to general anaesthesia in category 1 Caesarean section was 20%. A total of 8% of women had general anaesthesia when both primary general and conversion of regional anaesthesia were combined. The rate of failure to achieve a pain-free operation was 6% with spinals, 24% with epidural top-up and 18% with combined spinal-epidural. Besides the type of anaesthesia and operative urgency, other factors associated with pre-operative failure of regional anaesthesia included body mass index, no previous Caesareans, and indication for Caesarean of acute fetal distress or maternal medical condition. Inadequacy of pre-operative anaesthetic block and duration of surgery were important risk factors for intra-operative failure. For spinal anaesthesia, use of a spinal opioid was associated with less pre-operative failure. For epidural top-up anaesthesia, lower epidural top-up volume was associated with less pre-operative failure, and use of adrenaline was associated with both less pre-operative and intra-operative failure. The rate of serious adverse incidents was 1 : 126 with general anaesthesia and 1 : 501 with regional anaesthesia.

Entities:  

Mesh:

Year:  2008        PMID: 18547291     DOI: 10.1111/j.1365-2044.2008.05499.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  33 in total

1.  [Selection of the optimal anesthesia regimen for cesarean section].

Authors:  A-K Schubert; T Wiesmann; T Neumann; T Annecke
Journal:  Anaesthesist       Date:  2020-03       Impact factor: 1.041

Review 2.  Conversion of labour epidural analgesia to surgical anaesthesia for emergency intrapartum Caesarean section.

Authors:  N Desai; B Carvalho
Journal:  BJA Educ       Date:  2019-11-19

3.  Conservative management of subglottic stenosis in pregnancy resulting in vaginal birth.

Authors:  Zachary Nash; Archana Krishna; Mohamed Darwish; Lawrence Mascarenhas
Journal:  BMJ Case Rep       Date:  2014-04-03

4.  Failed spinal anaesthesia for caesarean section.

Authors:  Adenekan At; Olateju So
Journal:  J West Afr Coll Surg       Date:  2011-10

5.  Comparison of Patient Satisfaction Between General and Spinal Anaesthesia in Emergency Caesarean Deliveries.

Authors:  Arzu Açıkel; Tülün Öztürk; Aslı Göker; Gonca Gül Hayran; Gönül Tezcan Keleş
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

6.  Maternal and fetal outcomes following unplanned conversion to general anesthetic at elective cesarean section.

Authors:  C E Aiken; A R Aiken; J C Cole; J C Brockelsby; J H Bamber
Journal:  J Perinatol       Date:  2015-06-11       Impact factor: 2.521

7.  Anaesthesia for lower-segment caesarean section: Changing perspectives.

Authors:  Sean Brian Yeoh; Sng Ban Leong; Alex Sia Tiong Heng
Journal:  Indian J Anaesth       Date:  2010-09

Review 8.  Combined spinal-epidural versus spinal anaesthesia for caesarean section.

Authors:  Scott W Simmons; Alicia T Dennis; Allan M Cyna; Matthew G Richardson; Matthew R Bright
Journal:  Cochrane Database Syst Rev       Date:  2019-10-11

9.  Randomised Control Trial Comparing Plain Levobupivacaine and Ropivacaine with Hyperbaric Bupivacaine in Caesarean Deliveries.

Authors:  Divya Sethi
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-09-02

10.  Evaluation of failed and high blocks associated with spinal anesthesia for Cesarean delivery following inadequate labour epidural: a retrospective cohort study.

Authors:  Lisa M Einhorn; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2016-07-15       Impact factor: 6.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.